Roivant Sciences
ROIV
ROIV
294 hedge funds and large institutions have $5.77B invested in Roivant Sciences in 2024 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 102 increasing their positions, 84 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $5.6B → $5.77B (+$167M)
0% more funds holding in top 10
Funds holding in top 10: 19 → 19 (0)
12% less call options, than puts
Call options by funds: $14.4M | Put options by funds: $16.4M
Holders
294
Holding in Top 10
19
Calls
$14.4M
Puts
$16.4M
Top Buyers
| 1 | +$118M | |
| 2 | +$57.1M | |
| 3 | +$31.7M | |
| 4 |
TCA
Troluce Capital Advisors
Dorado,
Puerto Rico
|
+$31.2M |
| 5 |
Goldman Sachs
New York
|
+$28.6M |
Top Sellers
| 1 | -$66.6M | |
| 2 | -$49M | |
| 3 | -$48.8M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$33.5M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$26.3M |